Creating and Assessing a Voice Dataset for Automated Classification of Chronic Obstructive Pulmonary Disease

Sponsor
Blekinge Institute of Technology (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05897944
Collaborator
Excellence Center at Linköping - Lund in Information Technology (ELLIIT) (Other)
72
1
24.4
2.9

Study Details

Study Description

Brief Summary

This work aims to evaluate whether voice recordings collected from patients diagnosed with COPD and healthy control groups can be used to detect the disease using machine learning techniques.

Condition or Disease Intervention/Treatment Phase
  • Other: COPD

Detailed Description

Voice data and sociodemographic data on gender and age will be collected through the "VoiceDiganostic" application from the company Voice Diagnostic, which allows one to participate without location dependency. Participants with a diagnosis will be marked as the COPD group, and others will be marked as the healthy control group. Private information such as known comorbidities, personal security numbers, health parameters and communication information will be separately noticed in a participation table for each group.

The collected data will be transformed into mathematical vocal measures called voice features. A dataset consisting of voice features in conjunction with demographics and health data will be constructed for further usage as an input to ML techniques.

Descriptive statistical analysis will be held on attributes containing information on input data and gained outcomes from ML algorithms. The achieved results will be presented in the form of summary tables and graphs.

Study Design

Study Type:
Observational
Actual Enrollment :
72 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Creating and Assessing a Voice Dataset for Automated Classification of Chronic Obstructive Pulmonary Disease
Actual Study Start Date :
Dec 16, 2021
Actual Primary Completion Date :
May 16, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
COPD

Participants with clinically diagnosed Chronic obstructive pulmonary disease. Total 34 recruitment, 18 Female, 16 Male

Other: COPD
A data set consisting of information from COPD and HC groups will be used to experiment with the classification performance of several Machine Learning techniques.
Other Names:
  • HC
  • HC

    Participants without Chronic obstructive pulmonary disease diagnosis. Total 38 recruitment, 20 Female, 18 Male

    Other: COPD
    A data set consisting of information from COPD and HC groups will be used to experiment with the classification performance of several Machine Learning techniques.
    Other Names:
  • HC
  • Outcome Measures

    Primary Outcome Measures

    1. Accuracy [Week 51]

      Binary detection performance of the ML algorithm

    2. Input data importance scale [Week 51]

      Features used as input data will be ranked from most important to less important one.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • being 18 years old and older.
    Exclusion Criteria:
    • being under 18 years old.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Blekinge Institute of Technology Karlskrona Blekinge Sweden 37179

    Sponsors and Collaborators

    • Blekinge Institute of Technology
    • Excellence Center at Linköping - Lund in Information Technology (ELLIIT)

    Investigators

    • Principal Investigator: Johan Sanmartin Berglund, MD, PhD, Blekinge Institute of Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johan Sanmartin Berglund, Professor, MD, PhD, Blekinge Institute of Technology
    ClinicalTrials.gov Identifier:
    NCT05897944
    Other Study ID Numbers:
    • BTH-6.1.1-0074-2023
    First Posted:
    Jun 9, 2023
    Last Update Posted:
    Jun 12, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Johan Sanmartin Berglund, Professor, MD, PhD, Blekinge Institute of Technology
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 12, 2023